Anti-tuberculosis drug

Summary:

A German university offers lansoprazole sulfide as a drug to treat tuberculosis. The new drug is also active against multidrug-resistant tuberculosis. It has been tested in-vitro and in-vivo. Partners from the pharmaceutical industry are sought for licensing agreements.

Reference: TODE20180328002

Country: Germany

Submitted: 23. 7. 2018

View Partnering Opportunity

Keywords

Technology: Pharmaceutics, Gene - DNA Therapy, Pharmaceutical Products / Drugs

Market: Therapeutic, Pharmaceuticals/fine chemicals

NACE: -

Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.